Status:
COMPLETED
Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Microtia
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). Th...
Eligibility Criteria
Inclusion
- microtia patient
Exclusion
- non microtia patient
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00958802
Start Date
May 1 2009
End Date
September 1 2009
Last Update
November 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University, Wan Fang Hospital
Taipei, Taiwan, 116